DNAPRINT GENOMICS, INC.. (OTCBB: DNAG) was up 8.97% this morning in early trading.
DNAPrint Genomics, Inc. develops genomics-based products and services that focus on the drug development, pharmacogenomic diagnostic tests, and forensics technology and consumer genetic tests. Its primary product is PT-401, a >Super EPO= (erythropoietin) dimer protein drug for treatment of anemia in renal dialysis patients. The company=s other products under development include PT-401, which would be targeted to patients with a genetic profile indicating their propensity; OVANOME, a genomic-based diagnostic tool that matches ovarian cancer patients with the suitable form and dose of chemotherapy; and STATINOME, a test for the cardiac drug market to determine whether patients would be good or poor responders to statins. DNAPrint also offers ANCESTRYbyDNA and EURO-DNA, both are genome-based tests that determine genetic heritage; DNAWitness, which enables forensics experts in the law enforcement field to determine genetic heritage from DNA samples obtained from crime scenes; and RETINONE, another forensics product that can infer human iris (eye) color from DNA samples
Posted by matto on :
dnag 17.20% up usxp 14.29% up usxp primed and ready!
Posted by Fatso on :
quote:Originally posted by matto: usxp 14.29% up usxp primed and ready!
Any idea when an earnings report should be out?
Posted by matto on :
not sure but somethings brewing! love the fat finger * .007
Posted by Persia on :
DNAG going down.
Posted by blueranger on :
anybody playing dnag
Posted by gohigh on :
I'm playing it. I wonder if it's done going down yet. Seems like a company with a lot going for it. Nice little up move today.
Posted by djequipment on :
I've been holding DNAG for about 2 weeks. The chart really seems to be poised to take off.
![[Confused]](confused.gif)